WHO vaccine-preventable diseases: monitoring system. 2018 global summary

Last updated 15-Jul-2018 (data as of 15-Jul-2018)
Next overall update Winter 2018
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 12'7101 Infant (under 12 months) mortality rate: 42
GDP / capita (US$): 29'2911 Child (under 5 years) mortality rate: 52

Population data in thousands3

  2017  2016  2015  2014  2013  2000  1990  1980 
Total population 38'171  38'224  38'265  38'293  38'309  38'550  37'955  35'535 
Births 349  357  365  373  381  378  565  687 
Surviving infants 348  356  364  372  379  375  555  670 
Pop. less than 5 years 1'774  1'819  1'903  1'951  2'013  2'057  2'946  3'197 
Pop. less than 15 years 5'656  5'659  5'695  5'701  5'731  7'539  9'534  8'538 
Female 15-49 years 9'049  9'116  9'171  9'237  9'295  10'158  9'366  9'144 

Number of reported cases

(Click for retrospective incidence data for Poland)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  63  123  84  77  56'471  24'882 
Mumps
ChartChart
  1'670  1'978  2'436  17'548 
Pertussis
ChartChart
  3'066  6'853  2'183  2'269  292  232 
Polio*
ChartChart
 
Rubella
ChartChart
  476  1'105  38'546  46'181 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  11  12  14  14  65  89 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Poland)
Vaccine year result method % card seen                                                
BCG          92  93  94  92  93  96  97  93 
DTP1         
DTP3          96  98  98  98  99  98  96  96 
DTP4          91  91 
IPV1         
HepB_BD          95 
HepB3          93  95  96  96  96  99 
Hib3          96  98  98  98  99 
JapEnc         
MCV1          94  96  96  97  98  97  95  92 
MCV2          93  93  94  95  93  96 
MenA         
PCV1         
PCV2         
PCV3         
Pol3          90  92  92  94  95  98  96  96 
Rota1          96  97  98 
RotaC         
RCV1          94  96  98 
TT2plus         
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid July 2019

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Poland)
BCG
ChartChart
  93  93  94  92  93  96  97  93 
DTP1
ChartChart
  99  99  99  99  99  99  98  98 
DTP3
ChartChart
  98  98  98  98  99  98  96  96 
HepB3
ChartChart
  95  95  96  96  96  99 
HepB_BD
ChartChart
  93  93  93  93  93  95 
Hib3
ChartChart
  98  98  98  98  99 
IPV1
 
MCV1
ChartChart
  96  96  96  97  98  97  95  92 
MCV2
ChartChart
  93  93  94  95  93  96 
PCV3
 
Pol3
  92  92  92  94  95  98  96  96 
RCV1
ChartChart
  96  96  96  97  98  97  95 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 380  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2017 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 7-8 weeks; 3-4, 5-6, 16-18 months; Yes for those who cannot be given pertusis vaccine
DTaPHibIPV 7-8 weeks; 3-4, 5-6, 16-18 months; Yes risk groups who cannot be given whole-cell pertusus
DTwP 7-8 weeks; 3-4, 5-6, 16-18 months; Yes
HepB_Pediatric birth; 7-8 weeks; 7, 16-18 months; Yes
Hib 2, 3-4, 5-6, 16-18 months; Yes
Influenza_Adult >55 years; Yes and adults with chronic illness, pregnant women, health care workers, residents living in long-term care facilities
Influenza_Pediatric 0-18 years; Yes and children with chronic illness
IPV 3-4, 5-6, 16-18 months; 6 years; Yes
MMR 13-15 months; 10 years; Yes
Pneumo_conj 2, 4, 13 months;
Td 19 years; Yes and postexposure prophylaxis at a later age
TdaP 6, 14 years; Yes
TT Yes postexposure prophylaxis

Immunizaton indicators

Indicator Expected answer 2017  2016  2015  2014  2013  2012  2011 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No      No  No   
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number              

System performance

Total Nº districts in country number 380  380      344  379   
Nº districts with measles (MCV1) coverage >=95% number   NA           
% of districts with MCV1 coverage >=95% From 0 to 100%              

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No           
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes        Yes   

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%              

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes      Yes  Yes   

Sources

 1  "The 2018 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2018, data for 2016
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.